Krystal Biotech, Inc. - COMMON STOCK (KRYS)

CUSIP: 501147102

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / COMMON STOCK
Shares outstanding
29,067,614
Total 13F shares
20,979,177
Share change
+121,784
Total reported value
$1,678,957,589
Put/Call ratio
180%
Price per share
$80.06
Number of holders
159
Value change
+$9,326,151
Number of buys
75
Number of sells
65

Quarterly Holders Quick Answers

What is CUSIP 501147102?
CUSIP 501147102 identifies KRYS - Krystal Biotech, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q1 2023

As of 31 Mar 2023, Krystal Biotech, Inc. - COMMON STOCK (KRYS) was held by 159 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,979,177 shares. The largest 10 holders included FMR LLC, Redmile Group, LLC, Avoro Capital Advisors LLC, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, LORD, ABBETT & CO. LLC, Frazier Life Sciences Management, L.P., CREDIT SUISSE AG/, and PICTET ASSET MANAGEMENT SA. This page lists 159 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.